Skip to content
Find My Test
Pending

Invitae Multi-Cancer Panel

Invitae

This test has not received a published Test Grade yet.

A clinician-ordered germline genetic panel analyzing 71 genes associated with adult-onset hereditary cancer predisposition across multiple organ systems.

provider-confirmedSources documentedProvider identifiedLast verified August 15, 2026

Review status. This record is live for catalog testing, but its Test Grade and dimension scores are still awaiting editorial publication.

Best for

family-history, hereditary-cancer

Standout strength

The exact official test page documents 71 genes, a 10 to 21 day turnaround, accepted specimens, NGS methodology, and reported analytical performance.

Important watch-out

This is a clinician-order germline test, not a direct-to-consumer screening product and not a tumor somatic test. Price and insurance handling require confirmation.

Pending
Invitae Multi-Cancer Panel

Invitae

This test has not received a published Test Grade yet.

A clinician-ordered germline genetic panel analyzing 71 genes associated with adult-onset hereditary cancer predisposition across multiple organ systems.

provider-confirmedSources documentedProvider identifiedLast verified August 15, 2026

Review status. This record is live for catalog testing, but its Test Grade and dimension scores are still awaiting editorial publication.

Best for

family-history, hereditary-cancer

Standout strength

The exact official test page documents 71 genes, a 10 to 21 day turnaround, accepted specimens, NGS methodology, and reported analytical performance.

Important watch-out

This is a clinician-order germline test, not a direct-to-consumer screening product and not a tumor somatic test. Price and insurance handling require confirmation.

Next step

Check the panel or research the provider

Prices, availability, and ordering requirements can change. Confirm the current details before purchasing.

View exact panel on provider siteView Invitae profile

Scope, both directions

What it measures, and what it omits

Measured categories and focus areas

  • cancer-screening
  • genetics
  • family-history
  • hereditary-cancer

Important limits and omissions

  • This is a clinician-order germline test, not a direct-to-consumer screening product and not a tumor somatic test. Price and insurance handling require confirmation.

The full breakdown

Eight dimensions, each with its evidence

Open any published row for the reasoning and evidence behind the score. Missing dimensions stay visibly unpublished.

Dimension scores have not been published for this record.

What it asks of you

Sample and fulfillment journey

Order

Clinician order, Lab visit access. Confirm current state availability before buying.

Collect

blood, saliva, swab collection. Preparation requirements are shown when verified.

Return

Shipping and return requirements are not confirmed unless listed by the provider.

Lab

Method and laboratory documentation appear in the evidence section below.

Report

Current disclosed turnaround: 10 to 21 days.

Under the hood

Laboratory, method, and evidence sources

Every published claim should trace to a dated source. Missing evidence remains visible instead of being filled with assumptions.

Source 1Reviewed for this record. Last checked August 15, 2026.View source
Source 2Reviewed for this record. Last checked August 15, 2026.View source

True total cost

Pricing and add-ons

Pricing for Invitae Multi-Cancer Panel
ItemCurrent disclosed priceNote
PanelNot confirmedVerify the checkout total, shipping, and collection fees before ordering.
Optional servicesNot confirmedClinician review, subscriptions, and retesting discounts are listed only when documented.

Price status. This record shows disclosed pricing. Checkout costs can change and should be verified before purchase.

Your data

Privacy and data treatment

Privacy details are scored only when source documentation is available. Unconfirmed retention, deletion, research use, or marketing practices remain unconfirmed.

Reading the labels

Evidence states on this record

provider-confirmedSources documentedProvider identified

Confidence and verification labels stay separate from the Test Grade. They show how much source support exists for the evaluation.

The balance

Strengths and watch-outs

Strengths

  • The exact official test page documents 71 genes, a 10 to 21 day turnaround, accepted specimens, NGS methodology, and reported analytical performance.

Watch-outs

  • This is a clinician-order germline test, not a direct-to-consumer screening product and not a tumor somatic test. Price and insurance handling require confirmation.

Keep deciding

Compare selected testsExplore all testsFind my best-fit tests

Verification history

August 15, 2026Current record verification date.Current

Affiliate disclosure. Some outbound links may earn Labbrary a commission. Affiliate relationships never influence a Test Grade.